REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 3 filers reported holding REATA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,303,354 | +107.3% | 12,783 | +84.8% | 0.00% | – |
| Q1 2023 | $628,802 | +1820.1% | 6,916 | +702.3% | 0.00% | – |
| Q4 2022 | $32,748 | +31.0% | 862 | -13.4% | 0.00% | – |
| Q3 2022 | $25,000 | -61.5% | 995 | -53.2% | 0.00% | – |
| Q2 2022 | $65,000 | -80.3% | 2,126 | -78.9% | 0.00% | – |
| Q1 2022 | $330,000 | -55.0% | 10,082 | -63.8% | 0.00% | – |
| Q4 2021 | $734,000 | -61.6% | 27,845 | +46.4% | 0.00% | – |
| Q3 2021 | $1,913,000 | -9.5% | 19,019 | +27.3% | 0.00% | – |
| Q2 2021 | $2,114,000 | +109.1% | 14,938 | +47.3% | 0.00% | – |
| Q1 2021 | $1,011,000 | -22.2% | 10,142 | -3.4% | 0.00% | – |
| Q4 2020 | $1,299,000 | +3.1% | 10,499 | -18.9% | 0.00% | – |
| Q3 2020 | $1,260,000 | +1.6% | 12,950 | +62.9% | 0.00% | – |
| Q2 2020 | $1,240,000 | -44.4% | 7,952 | -48.6% | 0.00% | -100.0% |
| Q1 2020 | $2,231,000 | -39.1% | 15,464 | -13.7% | 0.00% | 0.0% |
| Q4 2019 | $3,663,000 | -46.8% | 17,920 | -79.1% | 0.00% | -50.0% |
| Q3 2019 | $6,888,000 | +100.2% | 85,793 | +135.3% | 0.00% | +100.0% |
| Q2 2019 | $3,441,000 | -7.3% | 36,468 | -16.0% | 0.00% | 0.0% |
| Q1 2019 | $3,710,000 | +45.9% | 43,407 | -4.2% | 0.00% | 0.0% |
| Q4 2018 | $2,542,000 | +33.6% | 45,306 | +94.7% | 0.00% | 0.0% |
| Q3 2018 | $1,903,000 | +140.9% | 23,265 | +2.9% | 0.00% | – |
| Q2 2018 | $790,000 | +85.9% | 22,599 | +9.2% | 0.00% | – |
| Q1 2018 | $425,000 | -67.7% | 20,691 | -55.5% | 0.00% | – |
| Q4 2017 | $1,317,000 | +19.8% | 46,467 | +31.4% | 0.00% | – |
| Q3 2017 | $1,099,000 | +524.4% | 35,372 | +532.7% | 0.00% | – |
| Q2 2017 | $176,000 | +89.2% | 5,591 | +37.4% | 0.00% | – |
| Q1 2017 | $93,000 | +5.7% | 4,070 | 0.0% | 0.00% | – |
| Q4 2016 | $88,000 | +54.4% | 4,070 | +88.7% | 0.00% | – |
| Q3 2016 | $57,000 | – | 2,157 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Conrad N. Hilton Foundation | 63,481 | $7,847,000 | 100.00% |
| CPMG Inc | 2,896,901 | $358,115,000 | 55.16% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 140,000 | $17,307,000 | 26.62% |
| Corriente Advisors, LLC | 525,000 | $64,901,000 | 15.45% |
| DUMAC, INC. | 76,050 | $9,401,000 | 7.33% |
| MADDEN SECURITIES Corp | 35,152 | $4,345,000 | 2.80% |
| Biondo Investment Advisors, LLC | 113,692 | $14,055,000 | 2.69% |
| Duquesne Family Office | 749,897 | $92,702,000 | 2.50% |
| LBJ Family Wealth Advisors, Ltd. | 30,368 | $3,754,000 | 2.44% |
| Integral Health Asset Management, LLC | 50,000 | $6,181,000 | 1.84% |